Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q2 2026 | ~2026-06-01 | $0.6000 |
| Q4 2025 | ~2026-04-01 | $0.5000 |
| Q2 2026 | ~2026-03-02 | $0.6000 |
| Q1 2025 | ~2025-12-01 | $0.6000 |
| Q1 2025 | 2025-11-13 | $0.6000 |
| Q3 2025 | ~2025-09-03 | $0.5500 |
| Q3 2025 | ~2025-06-02 | $0.5500 |
| Q4 2024 | ~2025-04-01 | $0.4700 |
| Q1 2024 | ~2025-03-03 | $0.5500 |
| Q1 2024 | ~2024-11-29 | $0.5500 |
| Q3 2024 | ~2024-08-26 | $0.5100 |
| Q2 2024 | ~2024-05-24 | $0.5100 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers… improve patient access to products and enhance patient care. The company delivers innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. Cencora distributes a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers located in the United States and select global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers. Additionally, the company furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance), niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions. The U.S. Healthcare Solutions segment distributes pharmaceuticals and provides services to healthcare providers and specialty physician practices. The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related service operations and global commercialization services.
- Name
- Cencora, Inc.
- Industry
- Medical Distribution
- CEO
- Robert P. Mauch · President and Chief Executive Officer
- Employees
- 51,000 as of 2025-09-30
- IPO Date
- 2018-09-21
- Phone
- (610) 727-7000
- Address
- 1 West First Avenue, Conshohocken, PA 19428-1800
- Website
- —
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| John Ciliberto | Executive Vice President and Chief Commercial Officer | — |
| Timothy Grayson | Executive Vice President and Chief Operating Officer | — |
| Kourosh Q. Pirouz | Senior Vice President, Group General Counsel and Corporate Secretary | — |
| Marcella Bushman | Executive Vice President, Chief Financial Officer | — |
| Robert P. Mauch | President and Chief Executive Officer | — |
Latest News
- 2026-04-25
-
2026-04-16
Cencora, Inc. $COR Shares Acquired by Assetmark Inc. defenseworld.net
- 2026-04-13
- 2026-04-12
-
2026-04-07
Reviewing KindlyMD (NASDAQ:NAKA) & Cencora (NYSE:COR) defenseworld.net
- 2026-04-01
- 2026-03-31
- 2026-03-24